Filing Flows › Quanterix (QTRX) › Q2 2026 › vs Q2 2025
Quanterix (QTRX) Q2 2026 vs Q2 2025 (year over year)
Quanterix's revenue rose $8.4M (+34%) from $24.5M in Q2 2025 to $32.9M in Q2 2026. The biggest changes: Spatial biology +$9.3M (—); Product revenue +$2.7M (+13%).
Quanterix, Q2 2026: revenue $32.9M (+34% year over year), operating margin -150.2%, net loss $48.9M, operating cash flow −$5.1M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Service and other revenue | $9.0M | $7.1M | $1.9M | +27% |
| Simoa | $6.0M | $7.1M | −$1.1M | -15% |
| Instruments | $3.7M | $2.0M | $1.7M | +87% |
| Research services | $3.0M | $4.0M | −$1.0M | -26% |
| Other | $1.7M | $516K | $1.2M | +237% |
| Product revenue | $23.4M | $20.7M | $2.7M | +13% |
| Spatial biology | $9.3M | $0 | $9.3M | — |
| Revenue | $32.9M | $24.5M | $8.4M | +34% |
| Other income, net | $443K | $7.0M | −$6.6M | -94% |
| Income tax benefit | $54K | $73K | −$19K | -26% |
| Net loss | $48.9M | $30.0M | $18.9M | +63% |
| Costs & expenses | $82.3M | $61.6M | $20.8M | +34% |
| Operating costs | $82.3M | $61.6M | $20.8M | +34% |
| Cost of revenue | $20.2M | $14.5M | $5.8M | +40% |
| Research & development | $7.8M | $9.1M | −$1.3M | -14% |
| SG&A | $27.4M | $30.4M | −$3.0M | -10% |
| Other operating costs | $26.9M | $7.7M | $19.3M | +251% |
| Operating cash sources | $48.9M | $30.0M | $18.9M | +63% |
| Depreciation & amortization | $6.1M | $2.0M | $4.1M | +207% |
| Share-based compensation | $4.2M | $5.4M | −$1.2M | -22% |
| Working capital & other | $33.5M | $17.0M | $16.5M | +97% |
| Cash used in operations | $5.1M | $5.7M | −$536K | -9% |
| Net loss absorbed | $48.9M | $30.0M | $18.9M | +63% |
Questions
How much did Quanterix's revenue grow year over year in Q2 2026?
Quanterix's revenue rose $8.4M (+34%) from $24.5M in Q2 2025 to $32.9M in Q2 2026.
What drove Quanterix's revenue change in Q2 2026?
Spatial biology +$9.3M (—); Product revenue +$2.7M (+13%).